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Abstract 
A novel NUMA1/PDGFRB fusion identified in B-
cell precursor acute lymphoblastic leukemia is 
described. 
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Identity 
t(5;11)(q33;q13) R-banding, courtesy Virginie Eclache. 
Clinics and pathology 
Disease 
B-cell precursor acute lymphoblastic leukemia 
(BCP-ALL). 
Phenotype/cell stem origin 
Common-B immunophenotype (B-II EGIL 
classification): CD19+, CD22+, CD79a+, CD10+, 
Cμ - 
Epidemiology 
Only one case described, a 61-year-old man. 
Treatment 
GRAAL 2012 (Group for Research in Adult Acute 
Lymphoblastic Leukemia). 
Cytogenetics 
Cytogenetics morphological 
Unbalanced t(5;11): 
t(5;11)(q33;q13),+der(5)t(5;11). 
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CGH analysis suggested a rearrangement between 
5q33 and 11q13. 
Genes involved and 
proteins 
PDGFRB (platelet-derived growth 
factor receptor, beta polypeptide) 
Location 
5q32 
DNA/RNA 
PDGFRB locus spans approximately 149.5 Mb and 
contains 23 exons. PDGFRB has been involved in 
over 30 gene fusion (Roberts, 2012; Kobayashi, 
2014). 
Protein 
The PDGRFB gene encodes a protein of 1106 amino 
acids with a molecular weight of approximately 124 
kDa. Tyrosine-protein kinase that acts as cell-surface 
receptor for homodimeric PDGFB and PDGFD and 
for heterodimers formed by PDGFA and PDGFB, 
and plays an essential role in the regulation of 
embryonic development, cell proliferation, survival, 
differentiation, chemotaxis and migration. Play an 
essential role in blood vessel development by 
promoting proliferation, migration and recruitment 
of pericytes and smooth muscle cells to endothelial 
cells. Binding of its cognate ligands - homodimeric 
PDGFB, heterodimers formed by PDGFA and 
PDGFB or homodimeric PDGFD - leads to the 
activation of several signaling cascades; the response 
depends on the nature of the bound ligand and is 
modulated by the formation of heterodimers between 
PDGFRA and PDGFRB. 
NUMA1 (nuclear mitotic apparatus 
protein 1) 
Location 
11q13.4 
DNA/RNA 
NUMA1 locus spans approximately 78 kb and 
contains 27 exons; NUMA1 has been involved in a 
gene fusion with RARA  (Wells RA, 1997; Melnick, 
1999) 
Protein 
The NUMA1 gene encodes a protein of 2115 amino 
acids with a molecular weight of approximately 230 
kDa. Highly abundant component of the nuclear 
matrix where it may serve a non-mitotic structural 
role, occupies the majority of the nuclear volume. 
Required for maintenance and establishment of the 
mitotic spindle poles, functioning as a tether linking 
bulk microtubules of the spindle to centrosomes. 
May be involved in coordination of the alignment of 
the mitotic spindle to the cellular polarity axis, which 
is a prerequisite for asymmetric cell divisions (Silk, 
2009). 
Result of the chromosomal 
anomaly 
Hybrid gene 
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Description 
5' NUTM1 - 3' PDGFRB. NUMA1 exon 22 is fused 
in frame with PDGFRB exon 11. 
Transcript 
The NUMA1-PDGFRB fusion transcript was 
amplified. 
Fusion protein 
 
NUTM1/PDGFRB fusion protein. 
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